{"id":88669,"date":"2023-11-20T09:42:45","date_gmt":"2023-11-20T04:12:45","guid":{"rendered":"http:\/\/finservwealth.com\/kotak-mutual-fund-launches-healthcare-fund-should-you-invest\/"},"modified":"2023-11-20T09:42:45","modified_gmt":"2023-11-20T04:12:45","slug":"kotak-mutual-fund-launches-healthcare-fund-should-you-invest","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/kotak-mutual-fund-launches-healthcare-fund-should-you-invest\/","title":{"rendered":"Kotak Mutual Fund launches healthcare fund. Should you invest?"},"content":{"rendered":"<p> Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance.<\/p><div id=\"finse-9758834\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/kotak-mutual-fund-launches-healthcare-fund-should-you-invest_17335471.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance. Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/kotak-mutual-fund-launches-healthcare-fund-should-you-invest_17335471.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/kotak-mutual-fund-launches-healthcare-fund-should-you-invest_17335471.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance. Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/mutual-funds\/kotak-mutual-fund-launches-healthcare-fund-should-you-invest_17335471.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-88669","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/h\/healthcare-mc_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/88669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=88669"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/88669\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=88669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=88669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=88669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}